For example, the C/EBPδ promoter is silenced in about 35% of human acute myeloid leukemia samples [74], and its expression is downregulated in the blast crisis phases of chronic myelogenous leukemia (CML) [75]. This evidence concerns the gene CEBPD and acute myeloid leukemia.